See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: Dec. 29, 2004

Anemia Generalized Anxiety Disorder (GAD) Renal Cell Carcinoma

(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:

Anemia

Researchers are currently recruiting subjects with anemia related to chronic kidney disease to participate in a research study testing an experimental drug.

Volunteers at least 18-years-old who have a history of Type II Diabetes may be eligible to participate.

The research site is in Sugar Land, Tex.

More Information

Please see http://www.centerwatch.com/patient/studies/cat373.html.

-----

Generalized Anxiety Disorder (GAD)

A research study is being prepared to evaluate the safety and effectiveness of an investigational medication for Generalized Anxiety Disorder (GAD).

Adults ages 18-64, who have been diagnosed with or experience symptoms of GAD may be eligible to participate.

The research site is in Clementon, N.J.

More Information

Please see http://www.centerwatch.com/patient/studies/cat414.html.

-----

Renal Cell Carcinoma

A study is underway to evaluate the safety and effectiveness of a drug for patients with renal cell cancer.

Volunteers at least 18-years-old who have metastatic renal cell carcinoma that can't be surgically removed may be eligible to participate.

The research sites are in Portland, Ore. and Houston, Tex.

More Information

Please see http://www.centerwatch.com/patient/studies/cat363.html.

-----

Copyright 2004 CenterWatch. All rights reserved.

Consumer News

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.